Dier Mardi
EVP and CFO at MDGL; CFO & Executive Vice President at RARE; EVP, CFO & CBO at PORTOLA PHARMACEUTICALS INC
- Sold, on record
- $17.4M
- Dollars the filings state
- Form 4 sales
- 27
- Latest Mar 6, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.EVP and CFO
- RAREUltragenyx Pharmaceutical Inc.CFO & Executive Vice President
- PORTOLA PHARMACEUTICALS INCEVP, CFO & CBO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- PORTOLA PHARMACEUTICALS INC266,050 shares
- RARE12,805 shares
- MDGL9,557 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale RAREPlan not statedMar 3 2022
Sold 954 shares at $65.71 ($63k)
Dier Mardi, CFO & Executive Vice President
Sold 1.8% of holdings ($3.5M position)51,808 shares leftFiling
- 2 Form 4 sale RAREPlan not statedOct 12 +223 days
Sold 3,484 shares at $38.22 ($133k)
Dier Mardi, CFO & Executive Vice President
Sold 4.9% of holdings ($2.7M position)68,324 shares leftFiling
- 3 Form 4 sale RAREPlan not statedOct 14 +2 days
Sold 1,629 shares at $40.16 ($65k)
Dier Mardi, CFO & Executive Vice President
Sold 2.4% of holdings ($2.7M position)66,695 shares left0.5x usual sizeFiling
- 4 Form 4 sale MDGLRoutineMar 3 +871 days
Sold 1,961 shares at $324.96 ($637k)
Dier Mardi, SVP and CFO
10b5-1 planSold 22.1% of holdings ($2.9M position)6,914 shares leftFirst sale on recordFiling
- 5 Form 4 sale MDGLRoutineMar 10 +7 days
Sold 258 shares at $323.04 ($83k)
Dier Mardi, SVP and CFO
10b5-1 planSold 2.4% of holdings ($3.5M position)10,440 shares leftFiling
- 6 Form 4 sale MDGLRoutineDec 2 +267 days
Sold 4,173 shares at $578.34 ($2.4M)
Dier Mardi, EVP and CFO
10b5-1 planSold 28.6% of holdings ($8.5M position)10,440 shares leftFiling
- 7 Form 4 sale MDGLNo planMar 2 +90 days
Sold 1,183 shares at $427.21 ($505k)
Dier Mardi, EVP and CFO
No 10b5-1 planSold 11.3% of holdings ($4.5M position)9,257 shares left0.6x usual sizeFiling
- 8 Form 4 sale MDGLRoutineMar 6 +4 days
Sold 1,982 shares at $430.87 ($854k)
Dier Mardi, EVP and CFO
10b5-1 planSold 13.7% of holdings ($6.2M position)12,490 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (27)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | MDGL | EVP and CFO | Form 4 sale | 1,982 | $854k | 13.7% | Routine | SEC |
| Mar 2, 2026 | MDGL | EVP and CFO | Form 4 sale | 1,183 | $505k | 11.3% | No plan | SEC |
| Dec 2, 2025 | MDGL | EVP and CFO | Form 4 sale | 4,173 | $2.4M | 28.6% | Routine | SEC |
| Mar 10, 2025 | MDGL | SVP and CFO | Form 4 sale | 258 | $83k | 2.4% | Routine | SEC |
| Mar 3, 2025 | MDGL | SVP and CFO | Form 4 sale | 1,961 | $637k | 22.1% | Routine | SEC |
| Oct 14, 2022 | RARE | CFO & Executive Vice President | Form 4 sale | 1,629 | $65k | 2.4% | Plan not stated | SEC |
| Oct 12, 2022 | RARE | CFO & Executive Vice President | Form 4 sale | 3,484 | $133k | 4.9% | Plan not stated | SEC |
| Mar 3, 2022 | RARE | CFO & Executive Vice President | Form 4 sale | 954 | $63k | 1.8% | Plan not stated | SEC |
| Oct 14, 2021 | RARE | CFO & Executive Vice President | Form 4 sale | 6,738 | $553k | 14.8% | Plan not stated | SEC |
| Apr 4, 2019 | PORTOLA PHARMACEUTICALS INC | EVP, CFO & CBO | Form 4 sale | 40,486 | $1.5M | 37.8% | Unusual | SEC |
| Jul 11, 2017 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 23,350 | $1.4M | 100.0% | Unusual | SEC |
| Jun 27, 2017 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 93,392 | $5.2M | 100.0% | Unusual | SEC |
| Mar 15, 2017 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 10,235 | $410k | 100.0% | Unusual | SEC |
| Sep 18, 2015 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 8,912 | $490k | 100.0% | Unusual | SEC |
| Jun 8, 2015 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 16,119 | $693k | 100.0% | Unusual | SEC |
| May 27, 2015 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 6,076 | $249k | 100.0% | Unusual | SEC |
| May 12, 2015 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 13,290 | $503k | 100.0% | Unusual | SEC |
| May 11, 2015 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 13,674 | $522k | 100.0% | Unusual | SEC |
| Feb 23, 2015 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 5,692 | $227k | 100.0% | Unusual | SEC |
| Nov 25, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 1,118 | $32k | 100.0% | Unusual | SEC |
| Aug 25, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 5,000 | $131k | 81.7% | Unusual | SEC |
| Jul 25, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 5,000 | $121k | 45.0% | Unusual | SEC |
| Jun 25, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 5,000 | $143k | 31.0% | Unusual | SEC |
| Jun 18, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 3,706 | $111k | 18.7% | Plan not stated | SEC |
| May 29, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 5,000 | $115k | 20.1% | Plan not stated | SEC |
| Apr 25, 2014 | PORTOLA PHARMACEUTICALS INC | Executive VP and CFO | Form 4 sale | 5,000 | $121k | 16.8% | Plan not stated | SEC |
| Mar 25, 2014 | PORTOLA PHARMACEUTICALS INC | Senior VP and CFO | Form 4 sale | 5,000 | $128k | 14.4% | Plan not stated | SEC |